Medicis bows out from battle over Inamed
This article was originally published in Clinica
Executive Summary
Allergan has emerged triumphant in its takeover bid for Inamed, after adversary Medicis Pharmaceuticals announced it was going to cut the breast implant maker loose from its previous merger agreement.